Prem Shah Biography and Net Worth

Prem Shah is Executive Vice President and Chief Pharmacy Officer, CVS Health and Co-President of CVS Pharmacy. In this role, Prem has oversight and responsibility for the company’s Omnichannel Pharmacy strategy focused on integration across all channels to make pharmacy interactions as personalized and seamless as possible, and meeting the health care needs of consumers when and where they want them, including at home, virtually and in the community.

Prior to his current role, Prem held several positions at CVS Health where he has provided strategic oversight of key Specialty Pharmacy functions to help deliver high quality patient care, while improving preference among physicians, health plans and health systems. Prior to joining CVS Health, Prem was Senior Vice President of ICORE, a Magellan Health Services Company. Previously he led the startup of the Specialty Pharmacy division at WellCare Health Plans, Inc. and served in other management roles.

Prem holds a Doctorate of Pharmacy from the University of Florida.

What is Prem S. Shah's net worth?: The estimated net worth of Prem S. Shah is at least $2.78 million as of February 16th, 2024. Mr. Shah owns 39,765 shares of CVS Health stock worth more than $2,784,743 as of April 23rd. This net worth approximation does not reflect any other investments that Mr. Shah may own. Learn More about Prem S. Shah's net worth.
How do I contact Prem S. Shah?: The corporate mailing address for Mr. Shah and other CVS Health executives is ONE CVS DR., WOONSOCKET RI, 02895. CVS Health can also be reached via phone at (401) 765-1500 and via email at [email protected]. Learn More on Prem S. Shah's contact information.
Has Prem S. Shah been buying or selling shares of CVS Health?: Prem S. Shah has not been actively trading shares of CVS Health over the course of the past ninety days. Most recently, Prem S. Shah sold 29,473 shares of the business's stock in a transaction on Friday, February 16th. The shares were sold at an average price of $76.95, for a transaction totalling $2,267,947.35. Following the completion of the sale, the executive vice president now directly owns 39,765 shares of the company's stock, valued at $3,059,916.75. Learn More on Prem S. Shah's trading history.
Who are CVS Health's active insiders?: CVS Health's insider roster includes Lisa Bisaccia (EVP), Eva Boratto (Former CFO), Troyen Brennan (EVP), James Clark (SVP), Alexander Cunningham (Exec. VP & COO of Aetna business ), Daniel Finke (EVP), Joshua Flum (EVP), Shawn Guertin (Exec. VP & CFO ), Alan Lotvin (EVP), Edward Ludwig (Director), Karen Lynch (EVP), Larry Merlo (Director), Thomas Moriarty (EVP), Jonathan Roberts (COO), and Prem Shah (EVP). Learn More on CVS Health's active insiders.
Are insiders buying or selling shares of CVS Health?: In the last twelve months, CVS Health insiders bought shares 2 times. They purchased a total of 16,000 shares worth more than $1,117,440.00. In the last twelve months, insiders at the pharmacy operator sold shares 2 times. They sold a total of 55,232 shares worth more than $4,197,811.63. The most recent insider tranaction occured on February, 16th when EVP Prem S Shah sold 29,473 shares worth more than $2,267,947.35. Insiders at CVS Health own 0.2% of the company. Learn More about insider trades at CVS Health.
Information on this page was last updated on 2/16/2024.

Prem S. Shah Insider Trading History at CVS Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/16/2024	Sell	29,473	$76.95	$2,267,947.35	39,765
4/8/2022	Sell	16,954	$105.00	$1,780,170.00	43,453
3/30/2022	Sell	5,346	$104.70	$559,726.20
3/17/2022	Sell	4,624	$106.65	$493,149.60

Prem S. Shah Buying and Selling Activity at CVS Health

CVS Health Company Overview

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Today's Range

Now: $69.26

$69.17

$70.21

50 Day Range

MA: $75.13

$68.58

$79.76

2 Week Range

Now: $69.26

$64.41

$83.25

Volume

2,350,308 shs

Average Volume

10,677,306 shs

Market Capitalization

$87.30 billion

P/E Ratio

10.72

Dividend Yield

3.81%

Beta

0.52

Healthcare Takes A Big Step Forward With The Help Of AI

From The Bull Report | Ad

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

Click here to see why this small company is trusted by the Mayo Clinic